Repligen Corp (NASDAQ:RGEN)

194.97
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
137.21
Today|||52-Week Range
262.26
+15.16%
Year-to-Date

Today’s Trading

Previous close194.97
Today’s open190.59
Day’s range189.72 - 197.38
Volume11,750
Average volume (3 months)604,040
Market cap$10.3B
Data as of 3:59pm ET, 01/27/2023

Growth & Valuation

Earnings growth (last year)+104.50%
Earnings growth (this year)+4.22%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+83.08%
P/E ratio67.5
Price/Sales22.62
Price/Book5.89

Competitors

----
SRPTSarepta Therapeutics...-0.02-0.02%
----
UTHRUnited Therapeutics ...+0.08+0.03%
Data as of 3:59pm ET, 01/27/2023

Financials

Next reporting dateFebruary 16, 2023
EPS forecast (this quarter)$0.58
Annual revenue (last year)$670.5M
Annual profit (last year)$128.3M
Net profit margin19.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts